Managing Dyspnea in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Canadian Thoracic Society Clinical Practice Guideline

dc.contributor.authorMarciniuk, Darcy D
dc.contributor.authorGoodridge, Donna
dc.contributor.authorHernandez, Paul
dc.contributor.authorRocker, Graeme
dc.contributor.authorBalter, Meyer
dc.contributor.authorBailey, Pat
dc.contributor.authorFord, Gordon
dc.contributor.authorBourbeau, Jean
dc.contributor.authorO’Donnell, Denis E
dc.contributor.authorMaltais, Francois
dc.contributor.authorMularski, Richard A
dc.contributor.authorCave, Andrew J
dc.contributor.authorMayers, Irvin
dc.contributor.authorKennedy, Vicki
dc.contributor.authorOliver, Thomas K
dc.contributor.authorBrown, Candice
dc.contributor.authorCanadian Thoracic Society COPD Committee Dyspnea Expert Working Group,
dc.date.accessioned2018-09-27T11:59:29Z
dc.date.available2018-09-27T11:59:29Z
dc.date.issued2011-01-01
dc.date.updated2018-09-27T11:59:29Z
dc.description.abstractDyspnea is a cardinal symptom of chronic obstructive pulmonary disease (COPD), and its severity and magnitude increases as the disease progresses, leading to significant disability and a negative effect on quality of life. Refractory dyspnea is a common and difficult symptom to treat in patients with advanced COPD. There are many questions concerning optimal management and, specifically, whether various therapies are effective in this setting. The present document was compiled to address these important clinical issues using an evidence-based systematic review process led by a representative interprofessional panel of experts.The evidence supports the benefits of oral opioids, neuromuscular electrical stimulation, chest wall vibration, walking aids and pursed-lip breathing in the management of dyspnea in the individual patient with advanced COPD. Oxygen is recommended for COPD patients with resting hypoxemia, but its use for the targeted management of dyspnea in this setting should be reserved for patients who receive symptomatic benefit. There is insufficient evidence to support the routine use of anxiolytic medications, nebulized opioids, acupuncture, acupressure, distractive auditory stimuli (music), relaxation, hand-held fans, counselling programs or psychotherapy. There is also no evidence to support the use of supplemental oxygen to reduce dyspnea in nonhypoxemic patients with advanced COPD.Recognizing the current unfamiliarity with prescribing and dosing of opioid therapy in this setting, a potential approach for their use is illustrated. The role of opioid and other effective therapies in the comprehensive management of refractory dyspnea in patients with advanced COPD is discussed.
dc.description.versionPeer Reviewed
dc.identifier.citationDarcy D Marciniuk, Donna Goodridge, Paul Hernandez, et al., “Managing Dyspnea in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Canadian Thoracic Society Clinical Practice Guideline,” Canadian Respiratory Journal, vol. 18, no. 2, pp. 69-78, 2011. doi:10.1155/2011/745047
dc.identifier.doihttps://doi.org/10.1155/2011/745047
dc.identifier.urihttp://hdl.handle.net/1880/108421
dc.language.rfc3066en
dc.rights.holderCopyright © 2011 Canadian Thoracic Society. This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes.
dc.titleManaging Dyspnea in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Canadian Thoracic Society Clinical Practice Guideline
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CRJ.2011.745047.pdf
Size:
567.85 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: